Table 1.

Patient demographics

n
Mean age (range), y57 (39-82)
Male/female7/5
WHO performance status at entry (0/1/2)4/6/0 (2 not stated)
Site of metastatic disease (%)
Liver8 (67)
Lung5 (42)
Bone1 (8)
Skin/lymph nodes6 (50)
Brain2 (17)
Previous therapy
Adjuvant high-dose IFN4
Adjuvant radiotherapy1
Palliative radiotherapy2
None6